American Cancer Society (2009). Cancer Facts and Figures 2009. Atlanta: American Cancer Society. Available online: http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf.pdf.
Ettinger DS (2008). Lung cancer and other pulmonary
neoplasms. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 1456-1465. Philadelphia: Saunders Elsevier.
Rivera MP (2009). Lung cancer in women: The difference in epidemiology, biology and treatment outcomes. Expert Review of Respiratory Medicine, 3(6): 627-634.
National Toxicology Program, U.S. Department of Health
and Human Services (2005). Report on Carcinogens, 11th
ed. Available online: http://ntp-server.niehs.nih.gov/ntp/roc/toc11.html.
National Comprehensive Cancer Network (2010). Non-Small Cell Lung Cancer,
version 2.2010. Available online:
Aldington S, et al. (2008). Cannabis use and risk of
lung cancer: A case-control study. European Respiratory Journal, 31(2): 280-286.
Fox JL, et al. (2004). The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer, 44(3): 287-293.
Dasgupta P, et al. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proceedings of the National Academy of Sciences, 103(16): 6332-6337.
Cassileth BR, et al. (2007). Complementary therapies and integrative oncology in lung cancer. Chest, 132: 340S-354S.
Temel JS, et al. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine, 363(8): 733-742.
Crawford J (2007). Lung cancer. In DC Dale, DD
Federman, eds., ACP Medicine, section 12, chap. 8. New
Godtfredsen NS, et al. (2005). Effect of smoking
reduction on lung cancer risk. JAMA, 294(12):
Goodman GE, et al. (2004). The beta-carotene and
retinol efficacy trial: Incidence of lung cancer and cardiovascular disease
mortality during 6-year follow-up after stopping beta-carotene and retinol
supplements. Journal of the National Cancer Institute,
Other Works Consulted
Abramowicz M (2003). Treatment guidelines: Drugs of
choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41-52.
Detterbeck FC, et al. (2009). Special feature: The new lung cancer staging system. Chest, 136: 260-271.
Erlotinib (Tarceva) for advanced non-small cell lung
cancer (2005). Medical Letter on Drugs and Therapeutics, 47(1205): 25-27.
National Cancer Institute (2009). Small Cell Lung Cancer PDQ: Treatment - Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/Patient.
National Cancer Institute (2010). Non-Small Cell Lung Cancer PDQ: Treatment - Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/healthprofessional/HealthProfessional.
National Cancer Institute (2010). Non-Small Cell Lung Cancer PDQ: Treatment - Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/patient.
National Cancer Institute (2010). Small Cell Lung Cancer PDQ: Treatment - Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/HealthProfessional.
Neville A (2009). Lung cancer, search date May 2008. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.